Journals / ESTÜDAM Halk Sağlığı Dergisi / 2020 / Cilt: 5 - COVID-19 Özel Sayısı

GLOBAL SURVEILLANCE STUDIES LED BY THE WORLD HEALTH ORGANIZATION IN THE PROCESS OF THE COVID-19 PANDEMIC

DÜNYA SAĞLIK ÖRGÜTÜ’NÜN COVID-19 PANDEMİSİNDE KÜRESEL SÜRVEYANS ÇALIŞMALARI

Pages
184–213
Publication Date
2020-09-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The principles of Public Health were emphasized by summarizing the global surveillance on outbreak management led by WHO with the characteristics of disease and agent during the first months of the pandemic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this review is to reveal the developments and studies under the leadership of the World Health Organization (WHO) in the first months of 2020 in the context of COVID-19 (Coronavirus disease-2019) and its causative agent, SARS-CoV-2, which was identified in December 2019 with published reports.
📊
Key Findings & Data:SARS-CoV-2, which takes place in the same family with SARS-CoV (Severe Acute Respiratory Syndrome-Coronavirus) and MERS-CoV (Middle East Respiratory Syndrome-Coronavirus), and has both similarities and differences with its family members, came up as the main topic on all over the World, leading to a pandemic and then an infodemia.
💡
Conclusion & Impact:The principles of Public Health were emphasized by summarizing the global surveillance on outbreak management led by WHO with the characteristics of disease and agent during the first months of the pandemic.
🔬Design:Review & Systematic Survey
📍Scope:2020 Verileri
⚙️Variables:Dünya Sağlık Örgütü · COVID-19 · sürveyans

Abstract

The aim of this review is to reveal the developments and studies under the leadership of the World Health Organization (WHO) in the first months of 2020 in the context of COVID-19 (Coronavirus disease-2019) and its causative agent, SARS-CoV-2, which was identified in December 2019 with published reports. SARS-CoV-2, which takes place in the same family with SARS-CoV (Severe Acute Respiratory Syndrome-Coronavirus) and MERS-CoV (Middle East Respiratory Syndrome-Coronavirus), and has both similarities and differences with its family members, came up as the main topic on all over the World, leading to a pandemic and then an infodemia. The principles of Public Health were emphasized by summarizing the global surveillance on outbreak management led by WHO with the characteristics of disease and agent during the first months of the pandemic.

Özet

Derlemenin amacı, 2019 Aralık ayında gündeme gelerek tanımlanan COVID-19 (Koronavirüs Hastalığı-2019) ve etkeni olan SARS-CoV-2 bağlamında 2020 yılının ilk aylarında Dünya Sağlık Örgütü önderliğinde yaşanan gelişmeleri ve çalışmaları, yayımlanan raporlar ile ortaya koymaktır. SARS-CoV (Ağır Akut Solunum Yetersizliği Sendromu ile ilişkili koronavirüs) ve MERS-CoV (Orta Doğu Solunum Sendromu ile ilişkili koronavirüs) ile aynı ailede yer alıp bu virüslerle olan benzerlikleri ve farklılıkları ile kendini gösteren SARS-CoV-2, önce bir pandemiye, ardından bir infodemiye yol açarak insanlık tarihindeki yerini almıştır. Pandeminin ilk aylarında ulaşılan hastalık ve etken ile ilgili bilgilerle beraber DSÖ önderliğindeki salgın yönetiminde küresel sürveyans özetlenerek halk sağlığı prensipleri vurgulanmıştır.

🔖

Cite This Article

GÖLBAŞI, S. D., METİNTAS, S. (2020). GLOBAL SURVEILLANCE STUDIES LED BY THE WORLD HEALTH ORGANIZATION IN THE PROCESS OF THE COVID-19 PANDEMIC. ESTÜDAM Halk Sağlığı Dergisi, Cilt: 5 - COVID-19 Özel Sayısı, 184–213. https://ajindex.com/articles/905427

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Buzgan T GÖ. Dünya Sağlık Örgütü’nün Pandemilerdeki Etkinliği ve Post-Pandemik Dönemdeki Geleceği COVID-19 Sürecinde DSÖ. Küresel Salgının Anatomisi: İnsan ve Toplumun Geleceği. Akademisi TB, editor. Ankara. 2020
  2. Interim report on WHO’s response to COVID - January - April 2020. Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme.: WHO; 29 April 2020 [Available from:
  3. Global surveillance for COVID-19 caused by human infection with COVID-19 virus, Interim guidance: WHO; 20 March 2020 [Available from:
  4. A guide to WHO’s guidance on COVID-19: WHO; 17 July 2020 [Available from:
  5. WHO Director-General's opening remarks at the media briefing on COVID-19: WHO; 8 April 2020 [Available from:
  6. Pneumonia of unknown cause – China: WHO; 5 January 2020 [Available from:
  7. Novel Coronavirus (2019-nCoV) situation report – 1: WHO; 21 January 2020 [Available from:
  8. Novel Coronavirus (2019-nCoV) situation report – 2: WHO; 22 January 2020 [Available from:
  9. Novel Coronavirus (2019-nCoV) situation report – 3 23 January 2020 [Available from:
  10. Novel Coronavirus (2019-nCoV) situation report – 4: WHO; 24 January 2020 [Available from:
  11. Laboratory testing of human suspected cases of novel coronavirus (‎‎‎‎‎‎‎‎nCoV)‎‎‎‎‎‎‎‎ infection: interim guidance: WHO Iris; 10 January 2020 [Available from:
  12. Timeline of WHO’s respo